Alnylam Pharmaceuticals, Inc.

GLENMEDE TRUST CO NA ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

675

Value ($000)

268

Weight

0.0%

2013 Q4 - 2025 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	268	0.0%	675	12/31/2025
2023 Q2	8/14/2023	408	0.0%	2,037	6/30/2023
2023 Q1	5/15/2023	408	0.0%	2,037	3/31/2023
2022 Q4	2/14/2023	484	0.0%	2,035	12/31/2022
2022 Q3	11/16/2022	410	0.0%	2,051	9/30/2022
2022 Q2	8/15/2022	298	0.0%	2,044	6/30/2022
2020 Q3	11/16/2020	27	0.0%	190	9/30/2020
2020 Q2	8/14/2020	27	0.0%	183	6/30/2020
2020 Q1	5/20/2020	21	0.0%	185	3/31/2020
2019 Q4	2/12/2020	21	0.0%	185	12/31/2019
2014 Q1	5/7/2014	161	0.0%	2,400	3/31/2014
2013 Q4	1/31/2014	173	0.0%	2,700	12/31/2013